SHERIDAN, WYOMING - April 13, 2026 - MedTech Europe submitted its formal response to the European Commission's public consultation on the forthcoming Integrated Climate Resilience Framework in February 2026, positioning the medical technology sector as a critical stakeholder in shaping how European healthcare systems adapt to climate-driven pressures. The submission calls for holistic system reform rather than fragmented policy responses, emphasizing that smart investment, cross-sector coordination, and coherent regulatory design are prerequisites for durable healthcare resilience. With the Commission targeting framework adoption in Q4 2026, the window for industry input is narrowing fast. The positions staked out now will directly shape the regulatory and investment environment that MedTech manufacturers face through the decade.
Why the Integrated Climate Resilience Framework matters
The European Climate Risk Assessment identified 36 distinct climate risks across Europe that interact to generate systemic, cross-sectoral challenges. Left unaddressed, these risks threaten supply chain continuity, pricing stability, economic and financial integrity, fiscal sustainability, and population health simultaneously. The Commission's decision to develop an integrated framework - rather than sectoral patches - reflects the scale of interdependency these risks create.
Healthcare systems sit at the convergence of most of these risk vectors. Extreme heat events increase demand for medical devices and consumables; supply chain disruptions caused by flooding or energy shocks can interrupt access to critical technologies; and fiscal stress on public health budgets limits the capacity to invest in climate-resilient infrastructure. The framework's Q4 2026 adoption timeline means concrete regulatory obligations and investment priorities for MedTech manufacturers could take legal form within 12 months.
MedTech Europe's core consultation positions
MedTech Europe's submission centers on three structural demands. First, the association calls for the Integrated Framework to enable climate resilience and risk management through active collaboration among all healthcare actors - manufacturers, payers, providers, and regulators - rather than top-down mandates that ignore operational realities. Unlocking system-level change, the submission argues, requires governance structures that create incentives for joint action.
Second, the submission specifically demands regulatory consistency with existing sector-specific legislation. EU Regulation 2017/745 on Medical Devices and EU Regulation 2017/746 on In-Vitro Diagnostic Medical Devices impose stringent requirements on device safety, performance, and market authorization. MedTech Europe warns that any new climate legislation must be explicitly reconciled with these frameworks to avoid conflicting compliance obligations that would slow innovation or disrupt supply. The association also calls for sustainability requirements to be assessed across the full product life cycle rather than at any single manufacturing or disposal stage.
Third, the submission demands realistic transition pathways for MedTech manufacturers and their manufacturing supply chains. Abrupt timelines risk interrupting patient and practitioner access to medical technologies - an outcome that cannot be traded off against environmental compliance targets. The association also argues for genuine harmonization of EU internal market rules, describing the single market as the strongest asset available for achieving both high environmental protection standards and a globally competitive European MedTech industry.
Green and Digital agenda convergence in healthcare
MedTech Europe's response endorses promoting global carbon pricing, expanding renewable energy use, and improving energy efficiency across healthcare operations. Crucially, the submission highlights the transformational potential of combining the EU's Green and Digital agendas within the healthcare sector. Digital health tools - from AI-assisted diagnostics to connected device networks - can reduce energy consumption, optimize supply chains, and improve clinical efficiency, delivering sustainability gains that purely regulatory mandates cannot achieve.
Tapping these synergies requires investment frameworks that treat digitalization and decarbonization as complementary rather than competing priorities. MedTech Europe's call for financial sustainability alongside resilience signals that the industry sees inadequate investment pathways as the primary barrier to delivering both goals simultaneously.
Business impact
Regulatory affairs and compliance teams at MedTech manufacturers face an immediate strategic task: mapping existing obligations under MDR (EU 2017/745) and IVDR (EU 2017/746) against the climate requirements likely to emerge from the Integrated Framework. If the Commission adopts requirements that do not account for sector-specific regulatory timelines, manufacturers could face overlapping or contradictory compliance cycles - forcing budget allocation decisions in 2026 planning rounds before the rules are finalized.
Supply chain and procurement leads must treat the 36 identified European climate risks as active sourcing variables rather than background context. Disruption scenarios affecting raw materials, logistics corridors, or energy supply for manufacturing sites require contingency sourcing strategies and supplier qualification processes that account for climate exposure. Procurement decisions made in 2026 will determine which supply chains are resilient enough to meet both regulatory and climate-resilience obligations when the framework takes force. Operations directors should begin internal transition-pathway assessments now, defining the minimum timelines their product portfolios require to shift manufacturing and logistics processes - and submitting those data points through industry channels before the Commission's Q4 2026 adoption date locks in the framework's transition provisions.